Skip to content

Artificial intelligence systems improve the quality of digestive endoscopy: a prospective self-controlled, single-center clinical trial

Artificial intelligence systems improve the quality of digestive endoscopy: a prospective self-controlled, single-center clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300068610
Enrollment
Unknown
Registered
2023-02-24
Start date
2023-02-28
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Precancerous lesion, intestinal adenoma

Interventions

experimental group:Artificial intelligence assisted
control group:no Artificial intelligence assisted

Sponsors

Hainan General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1) Male or female aged 18 years or above; 2) Digestive endoscopy should be performed to further clarify the characteristics of digestive tract diseases; 3) Able to read, understand and sign informed consent; 4) The investigator believed that the subjects understood the clinical study procedures, were willing and able to complete all study procedures and follow-up visits, and cooperate with the study procedures.

Exclusion criteria

Exclusion criteria: 1) Have participated in other clinical trials, signed informed consent and are in the follow-up period of other clinical trials; 2) Drug or alcohol abuse or psychological disorder in the last 5 years; 3) Pregnant or lactating women; 4) Subjects with a history of gastrointestinal surgery; 5) The investigator believes that the subjects are not suitable for digestive endoscopy; 6) High-risk diseases or other special conditions for which the investigator considers subjects unsuitable for clinical trials.

Design outcomes

Primary

MeasureTime frame
Detection rate of gastric precancerous lesions;Detection rate of intestinal adenoma;

Secondary

MeasureTime frame
The blind area rate of gastroscopy;Detection rate of early gastric cancer;The detection rate of adenoma in different sites;Receding time;Polyp detection rate;

Countries

China

Contacts

Public ContactLancheng

Hainan General Hospital

lancheng@163.com13078985175

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026